Stay updated on Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.

Latest updates to the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page
- ChecktodayChange DetectedThe page’s revision history shows an added Revision: v3.3.4 and a removal of Revision: v3.3.3. This is a minor housekeeping update with no impact on study content or user-facing functionality.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedDifference3%

- Check51 days agoChange DetectedThe page now includes a note that PubMed-pulled publications may not all pertain to the study, and the Revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedThe government funding status notice was removed from the page, with no evident changes to trial details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check73 days agoChange DetectedNo additions or deletions were observed on the page; the study details content remains unchanged.SummaryDifference0.1%

- Check87 days agoChange DetectedUpdated location data: removing several 2024-era addresses and adding new 2025 entries across multiple countries, notably including Amsterdam (North Holland) and various new international locations.SummaryDifference4%

Stay in the know with updates to Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.